Tariffs
← Отчётные звонки
01
02
03
04 05 06
Тон
A1 A2 A3 A4
KVUE
FY2025 Q1
Ослабевает
Отчётный звонок Kenvue Inc.
Вывод Buzzberg
Tariffs to cause $150M gross 2025 cost impact
Kenvue's Q1 results were in line with its muted expectations, but FY25 EPS and margin guidance were lowered due to tariff assumptions. Management highlighted some strong consumption/share gains in the US offset by China destocking and category softness, updating its outlook to reflect a highly uncertain environment. Q1 organic sales declined 0.2% year-over-year, consistent with guidance, but adjusted EPS of $0.24 was reported with a $0.02 currency headwind.
Вывод Buzzberg Tariffs to cause $150M gross 2025 cost impact Kenvue's Q1 results were in line with its muted expectations, but FY25 EPS and margin guidance were lowered due to tariff assumptions. Management highlighted some strong consumption/share gains in the US offset by China destocking and category softness, updating its outlook to reflect a highly uncertain environment. Q1 organic sales declined 0.2% year-over-year, consistent with guidance, but adjusted EPS of $0.24 was reported with a $0.02 currency headwind. Читать полный анализСвернуть анализ
Kenvue's Q1 results were in line with its muted expectations, but FY25 EPS and margin guidance were lowered due to tariff assumptions. Management highlighted some strong consumption/share gains in the US offset by China destocking and category softness, updating its outlook to reflect a highly uncertain environment. Q1 organic sales declined 0.2% year-over-year, consistent with guidance, but adjusted EPS of $0.24 was reported with a $0.02 currency headwind.
- FY25 adjusted EPS and operating margin guidance were both lowered to reflect the estimated $150M gross tariff impact, with EPS now expected to be flat year-over-year.
- FY25 net sales growth from FX improved to 1-3% from 0-2% due to a weaker dollar; organic sales growth outlook maintained at -4% to 0%.
- Consumption outpaced organic sales growth in all segments in Q1, signaling share gains and successful US price/trade initiatives, particularly in self-care and skin health.
Выручка$3.741BФакт
EPS$0.24Факт
Валовая маржа57.95%Факт
Операционная маржа14.92%Факт
6 подтверждённых тезисов
Что важно сейчас
Самые значимые изменения по итогам звонка.
Guidance
Q1 organic sales declined 0.2% as planned
Guidance
Company maintains 2025 organic sales growth outlook of 2-4%
Показать ещё 3 тезиса
Leadership
CFO transition: Amit Banati joins May 12
Demand
China destocking headwind expected to end by Q2
Margins
Adjusted operating margin now expected to contract slightly for full year
Отчётный период
Фактические результаты
| Показатель | Факт | Изменение |
|---|---|---|
| Выручка | $3.741B | Факт |
| EPS | $0.24 | Факт |
| Валовая маржа | 57.95% | Факт |
| Операционная маржа | 14.92% | Факт |
| Свободный денежный поток | $0.249B | Факт |
| Капзатраты | $0.179B | Факт |
Прогнозные данные
Прогноз компании
| Показатель | Период | Диапазон | Середина | Статус |
|---|---|---|---|---|
| EPS | FY2025 | $0.00 | $0.00 | Понижен |
| Операционная маржа | FY2025 | 0% | 0% | Понижен |
| Выручка | FY2025 | $0B | $0B | Подтверждён |
AI, капзатраты и спрос
Оценка менеджмента
Cautious
Management acknowledged a dynamic and fluid macro environment, including tariffs, category deceleration, and seasonal shifts, while expressing confidence in their strategic plan and back-half acceleration.
все упомянутые компании ниже: 8
Компаниис момента звонка
Партнёры
Партнёры
Thibaut Mongone
Kenvue's full exit from J&J's transition services agreements marks its independence, potentially freeing it from legacy overhead but also ending a revenue stream for J&J.
Доказательства
“In April, we reached a major operational milestone, completing our transition services agreement program, finalizing the exit of more than 2,300 TSAs as per plan and without any disruption to our business.”
Цепочка поставок
Цепочка поставок
Thibaut Mongone
The incoming CFO's history at Kellanova is mentioned in a Q&A; it's a reference to his background, not a statement about either company's current trajectory.
Доказательства
“he's probably most closely associated today with seeing Kellogg through the Kellenova WK Kellogg separation and the subsequent sale of Kellenova to Mars.”
Цепочка поставок
Thibaut Mongone
April US retail orders tightened, which combined with a delayed allergy/sun season, may shift volumes into later quarters. — This signals the consumer staples sector overall faces a near-term demand pull-forward/deferral dynamic, potentially pressuring H1 sales for peers while setting up a potentially stronger H2.
Доказательства
“from a macro point of view, we have seen some retailers tightening order management in April in the US. So these two factors may shift volumes from one quarter to the next.”
Цепочка поставок
Thibaut Mongone
Consumption outpaced organic sales growth across all segments in Q1, driven by US price/trade investment, indicating Kenvue is gaining share and household penetration in the US despite retailer destocking. — This suggests the US price/trade investments are driving market share gains for Kenvue, indicating a competitive pricing response from Kenvue that could pressure US market share for peers like Church & Dwight and L'Oreal.
Доказательства
“Globally, we are activating our five extraordinary powers, driving stronger consumption performance for the company in Q1 relative to Q4. In fact, consumption for the quarter outpaced organic sales growth across each of our three segments.”
Внешние сигналы
Альфа цепочки поставок · 4с момента звонка
Kenvue's gross tariff impact is ~$150M, with ~two-thirds coming from China (at a 145% rate), and the largest import flow being finished goods from Canada (netting to <10% impact after MCA exemptions).
Доказательства
“The biggest importer is Canada, Canada into the US, and most of that is finished goods... It's about two-thirds of the analyzed impact at the current rate of 145%. To give a little more color, two-thirds is finished products, about one-thi…”
April US retail orders tightened, which combined with a delayed allergy/sun season, may shift volumes into later quarters.
Consumption outpaced organic sales growth across all segments in Q1, driven by US price/trade investment, indicating Kenvue is gaining share and household penetration in the US despite retailer destocking.
Tylenol gained share for the 11th straight quarter and was the only brand in its category gaining value and volume share, while Zyrtec grew both value and volume share.
Доказательства
“we capitalize on the seasonal spike in the U.S. and strengthen Tylenol's number one position, gaining share for the 11th straight quarter and widening the gap further with competition. And once again, Tylenol was the only brand in the cate…”
Методология и полнота
Анализ основан только на заявлениях менеджмента. Показаны все подтверждённые упоминания компаний: 8. Фактические результаты и прогнозы разделены. Публичные доказательства ограничены восемью короткими атрибутированными цитатами. AI-анализ может быть неполным или ошибочным — проверяйте важные утверждения по первоисточнику.